{"transactions":[{"id":409614,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-28T21:34:59.000Z","date":"2018-12-27","kind":"purchase","acquired":true,"shares":27461,"price":24.9487,"value":685116.2507,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.85 and $25.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5380940,"source":{"system":"sec-edgar","filing":"0001209191-18-064322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064322/doc4.xml","form_type":"4"}},{"id":409613,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-28T21:34:59.000Z","date":"2018-12-26","kind":"purchase","acquired":true,"shares":12737,"price":24.8942,"value":317077.4254,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.69 and $25.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5353479,"source":{"system":"sec-edgar","filing":"0001209191-18-064322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064322/doc4.xml","form_type":"4"}},{"id":409656,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-26T21:35:40.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":53655,"price":24.9687,"value":1339695.5985,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.82 and $25.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5340742,"source":{"system":"sec-edgar","filing":"0001209191-18-064099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064099/doc4.xml","form_type":"4"}},{"id":409655,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-26T21:35:40.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":11742,"price":23.1766,"value":272139.6372,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.02 and $23.25."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5287087,"source":{"system":"sec-edgar","filing":"0001209191-18-064099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064099/doc4.xml","form_type":"4"}},{"id":409654,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-26T21:35:40.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":2603,"price":22.9147,"value":59646.9641,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.69 and $23.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5275345,"source":{"system":"sec-edgar","filing":"0001209191-18-064099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064099/doc4.xml","form_type":"4"}},{"id":409653,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":16041,"kind":"organization","name":"Vertex Pharmaceuticals (Europe) Ltd","position":1,"cik":"0001761216","reported_name":"Vertex Pharmaceuticals (Europe) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":2,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-12-26T21:35:40.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":22742,"price":22.5784,"value":513477.9728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.46 and $22.70."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are directly held by Vertex Pharmaceuticals (Europe) Limited (\"Vertex Europe\"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe."}],"balance_after":5272742,"source":{"system":"sec-edgar","filing":"0001209191-18-064099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118064099/doc4.xml","form_type":"4"}},{"id":602365,"issuer":{"id":17384,"kind":"organization","name":"Altus Pharmaceuticals Inc.","symbol":"ALTU"},"owners":[{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":1,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2006-08-02T16:43:08.000Z","date":"2006-07-31","kind":"sale","acquired":false,"shares":817749,"price":14.28,"value":11677455.72,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-06-000072","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000072/edgar.xml","form_type":"4"}},{"id":620729,"issuer":{"id":17384,"kind":"organization","name":"Altus Pharmaceuticals Inc.","symbol":"ALTU"},"owners":[{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":1,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2006-02-02T20:44:18.000Z","date":"2006-01-31","kind":"exercise","acquired":false,"shares":381596,"price":5.73,"value":2186545.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the conversion of shares of Series A Preferred Stock into shares of common stock in connection with the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":5.73,"exercise_date":"2006-01-31","expiration_date":"2006-01-31","underlying":"Common Stock","underlying_shares":381596},"source":{"system":"sec-edgar","filing":"0000875320-06-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000007/edgar.xml","form_type":"4"}},{"id":620728,"issuer":{"id":17384,"kind":"organization","name":"Altus Pharmaceuticals Inc.","symbol":"ALTU"},"owners":[{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX","position":1,"cik":"0000875320","reported_name":"VERTEX PHARMACEUTICALS INC / MA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2006-02-02T20:44:18.000Z","date":"2006-01-31","kind":"exercise","acquired":true,"shares":381596,"price":5.73,"value":2186545.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the conversion of shares of Series A Preferred Stock into shares of common stock in connection with the closing of the Issuer's initial public offering."}],"balance_after":381596,"source":{"system":"sec-edgar","filing":"0000875320-06-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000007/edgar.xml","form_type":"4"}}]}